BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36451443)

  • 21. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.
    Han W; Bu X; Liu Y; Liu F; Ren Y; Cui Y; Kong S
    World J Surg Oncol; 2021 Sep; 19(1):283. PubMed ID: 34537058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
    Zhang LX; Wei ZJ; Xu AM; Zang JH
    Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
    Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
    World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
    Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
    [No Abstract]   [Full Text] [Related]  

  • 26. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer.
    Han XL; Yi CL; Ma JD; He Y; Wu LM; Wang YF; Yang HJ; Liang DY; Shi JF
    Lab Med; 2022 Jan; 53(1):71-77. PubMed ID: 34508270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer.
    Li D; Lu Y; Zhao F; Yan L; Yang X; Wei L; Yang X; Yuan X; Yang K
    PeerJ; 2022; 10():e14115. PubMed ID: 36221263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
    Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
    PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of plasma exosomal circLPAR1 in patients with gastric cancer and its clinical application value.
    Yang X; Xia J; Peng C; Cai W
    Am J Cancer Res; 2023; 13(9):4269-4276. PubMed ID: 37818058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance and usefulness of soluble heparin binding-epidermal growth factor in gastric cancer.
    Chung HW; Kong HY; Lim JB
    World J Gastroenterol; 2015 Feb; 21(7):2080-8. PubMed ID: 25717241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive evaluation of serum circHAS2 as a novel diagnostic and prognostic biomarker for gastric cancer.
    Ma S; Yao Y; Xu Y; Zou M; Zhou M; Abudushalamu G; Chen Y; Cai S; Zhang C; Wu G
    Mol Carcinog; 2024 Jan; 63(1):94-105. PubMed ID: 37750590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic performance of serum LIM homeobox transcription factor 1 alpha in patients with gastric cancer.
    Li D; Li C
    Medicine (Baltimore); 2019 May; 98(22):e15783. PubMed ID: 31145300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].
    Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
    Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
    World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
    Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
    BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic atrophic gastritis in association with hair mercury level.
    Xue Z; Xue H; Jiang J; Lin B; Zeng S; Huang X; An J
    Tumour Biol; 2014 Nov; 35(11):11391-8. PubMed ID: 25119602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
    Lim JB; Chung HW
    Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.